about
Dupilumab in the treatment of moderate-to-severe atopic dermatitis.The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis.Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.Pseudolaric acid B attenuates atopic dermatitis-like skin lesions by inhibiting interleukin-17-induced inflammation.Atopic Dermatitis in Animals and People: An Update and Comparative Review.The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.A Pilot Qualitative Investigation of Stakeholders' Experiences and Opinions of Equine Insect Bite Hypersensitivity in England.Baicalein Promotes Neuronal and Behavioral Recovery After Intracerebral Hemorrhage Via Suppressing Apoptosis, Oxidative Stress and Neuroinflammation.Effect of isoliquiritigenin for the treatment of atopic dermatitis-like skin lesions in mice.Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis.
P2860
Q39122316-21C56C64-AAD8-498E-ADDF-87EDDC57ABE5Q39402846-01AF8C83-8F80-4464-BBAB-70FDC6306FC0Q39410617-00AF617E-8E1C-4459-A9E6-C4318D628F6DQ41366939-45D10E76-A2B0-46F3-BF52-2AD32F7244BCQ45601105-A28EB1A4-68DE-43B6-A1F3-2EC6F62B5E3DQ47144191-D8D908CC-98C7-43DE-AC71-BB9F227FDBBCQ47743692-C690C4AD-B359-4073-B14B-DD9543D66532Q47988706-BD73B794-F8D6-46B9-A443-C79F68F95800Q50062293-7709BC70-9776-457F-8E01-78CB04F4AC99Q50129104-A500C80F-A675-4F88-8500-474D91FF48AF
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Anti-inflammatory therapies in atopic dermatitis.
@en
type
label
Anti-inflammatory therapies in atopic dermatitis.
@en
prefLabel
Anti-inflammatory therapies in atopic dermatitis.
@en
P2860
P356
P1433
P1476
Anti-inflammatory therapies in atopic dermatitis.
@en
P2093
A Heratizadeh
P2860
P304
P356
10.1111/ALL.13065
P577
2016-10-13T00:00:00Z